The half-life of the isospin T = 1/2 mirror β + decay of 21 Na was measured at the GANIL-SPIRAL radioactive ion beam facility to be T 1/2 = 22.422 (10) s, a result that is more than a factor of 5 times more precise than the previous world average, with a resulting f t value that is now two times more precise. The precision of this new result implies that the half-life is no longer the dominant source of uncertainty in the Ft value used in the calculation of V ud from mirror decays to test the conserved vector current hypothesis of the standard model. The value of V ud deduced from mirror decays using the new half-life result is now in better agreement with the V ud derived from T = 1 superallowed 0 + to 0 + transitions.
A new 1D radial fluid code, IMAGINE, is used to simulate the penetration of gas into a tokamak plasma during a Massive Gas Injection (MGI). The main result is that the gas is in general strongly braked as it reaches the plasma, due to mechanisms related to charge exchange and (to a smaller extent) recombination. As a result, only a fraction of the gas penetrates into the plasma. Also, a shock wave is created in the gas which propagates away from the plasma, braking and compressing the incoming gas. Simulation results are quantitatively consistent, at least in terms of orders of magnitude, with experimental data for a D 2 MGI into a JET Ohmic plasma. Simulations of MGI into the background plasma surrounding a runaway electrons beam show that if the background electron density is too high, the gas may not penetrate, suggesting a possible explanation to the recent results of Reux et al. in JET [1].
Since 2001, the SPIRAL 1 facility has been one of the pioneering facilities in ISOL techniques for reaccelerating radioactive ion beams: the fragmentation of the heavy ion beams of GANIL on graphite targets and subsequent ionization in the Nanogan ECR ion source has permitted to deliver beams of gaseous elements (He, N, O, F, Ne, Ar, Kr) to numerous experiments. Thanks to the CIME cyclotron, energies up to 20 AMeV could be obtained. In 2014, the facility was stopped to undertake a major upgrade, with the aim to extend the production capabilities of SPIRAL 1 to a number of new elements. This upgrade, which is presently under commissioning, consists in the integration of an ECR booster in the SPIRAL 1 beam line to charge breed the beam of different 1+ sources. A FEBIAD source (the so-called VADIS from ISOLDE) was chosen to be the future workhorse for producing many metallic ion beams. This source was coupled to the SPIRAL 1 graphite targets and tested on-line with different beams at GANIL. The charge breeder is an upgraded version of the Phoenix booster which was previously tested in ISOLDE. It was lately commissioned at LPSC and more recently in the SPIRAL 1 beam lines with stable beams. The upgrade additionally permits the use of other target material than graphite. In particular, the use of fragmentation targets will permit to produce higher intensities than from projectile fragmentation, and thin targets of high Z will be used for producing beams by fusion-evaporation. The performances of the aforementioned ingredients of the upgrade (targets, 1+ source and charge breeder) have been and are still being optimized in the frame of different European projects (EMILIE, ENSAR and ENSAR2). The upgraded SPIRAL 1 facility will provide soon its first new beams for physics and further beam development are undertaken to prepare for the next AGATA campaign. The results obtained during the on-line commissioning period permit to evaluate intensities for new beams from the upgraded facility.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.